Optimal dose of etanercept in the treatment of rheumatoid arthritis

QR Code

Optimal dose of etanercept in the treatment of rheumatoid arthritis

Elizabeth Mary Curtis, Jonathan Lewis MarksDepartment of Rheumatology, University Hospital Southampton, Southampton, Hampshire, UKAbstract: Etanercept (ETN) is one of a number of biological therapies targeting the proinflammatory cytokine tumor necrosis factor-alpha that have demonstrated efficacy...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Curtis EM, Marks JL
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2014
Sujets:	Diseases of the musculoskeletal system RC925-935
Accès en ligne:	https://doaj.org/article/d11f11d8cc3d4f50ad7576ab43040d03
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis
par: Michihito Sato, et autres
Publié: (2011)

Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study
par: Franz Thiele, et autres
Publié: (2021)

Certolizumab in the long-term treatment of rheumatoid arthritis
par: Scott DL, et autres
Publié: (2011)

Long-term treatment of rheumatoid arthritis with adalimumab
par: Murdaca G, et autres
Publié: (2013)

New and emerging therapies for the treatment of rheumatoid arthritis
par: Michael G Feely
Publié: (2010)

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
par: Takeo Isozaki, et autres
Publié: (2010)

Rheumatoid arthritis: Disease or syndrome?
par: Jessica A Stanich, et autres
Publié: (2009)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
par: Augustine JM, et autres
Publié: (2012)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
par: Peter BB Jones, et autres
Publié: (2010)

Genetics of rheumatoid arthritis: GWAS and beyond
par: McAllister KM, et autres
Publié: (2011)

Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany
par: Wollenhaupt J, et autres
Publié: (2013)

Update on the use of rituximab for intractable rheumatoid arthritis
par: R John Looney
Publié: (2009)

Rheumatoid arthritis-associated interstitial lung disease
par: Brown KK, et autres
Publié: (2012)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
par: Masahiko Mihara, et autres
Publié: (2011)

Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
par: Fabrizio Cantini, et autres
Publié: (2009)

Goals for rheumatoid arthritis: treating to target or treating to prevent?
par: Yang M, et autres
Publié: (2012)

Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
par: Joseph R Lutt
Publié: (2009)

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
par: Michaël Doumen, et autres
Publié: (2021)

Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis
par: Bello AE, et autres
Publié: (2017)

Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?
par: Mena Soory
Publié: (2010)

The use of administrative health care databases to identify patients with rheumatoid arthritis
par: Hanly JG, et autres
Publié: (2015)

Patients’ Perceptions of Person‐Centered Care in Early Rheumatoid Arthritis: A Qualitative Study
par: Ellen Landgren, et autres
Publié: (2021)

The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life
par: Roy Fleischmann
Publié: (2009)

Optimal management of dactylitis in patients with psoriatic arthritis
par: Yamamoto T
Publié: (2015)

Incidence density of serious infection, opportunistic infection, and tuberculosis associated with biologic treatment in patients with rheumatoid arthritis &ndash; a systematic evaluation of the literature
par: Tran TN, et autres
Publié: (2013)

Serum anticyclic citrullinated protein antibody titers are correlated with the response to biological agents in patients with rheumatoid arthritis
par: Takahashi R, et autres
Publié: (2014)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
par: Mysler E, et autres
Publié: (2021)

The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation
par: Townes SV, et autres
Publié: (2012)

Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study
Publié: (2021)

Treatment of systemic-onset juvenile arthritis with canakinumab
par: Peitz J, et autres
Publié: (2015)

Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
par: Murakami M, et autres
Publié: (2012)

Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
par: Gian Luca Erre, et autres
Publié: (2021)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
par: Ulusoy H, et autres
Publié: (2020)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
par: Montepaone M, et autres
Publié: (2014)

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study
par: Patricia Bogas, et autres
Publié: (2021)

Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
par: Al-Ani N, et autres
Publié: (2021)

The onset of rheumatoid arthritis following trauma
par: Brawer AE, et autres
Publié: (2016)

Different T cells' distribution and activation degree of Th17 CD4+ cells in peripheral blood in patients with osteoarthritis, rheumatoid arthritis, and healthy donors: preliminary results of the MAGENTA CLICAO study
par: Lurati A, et autres
Publié: (2015)

Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
par: Ríos C, et autres
Publié: (2017)

The patient perspective: arthritis care provided by Advanced Clinician Practitioner in Arthritis Care program-trained clinicians
par: Warmington K, et autres
Publié: (2015)